Expression levels of Lnc BRM together with YAP1 signaling targets are correlated with tumor severity og HCC patients and, therefore, lnc BRM and YAP1 signaling may serve as biomarkers for diagnosis and potential drug targets for HCC [169]. Here, SMARCA2 is linked to neoplasm.